Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1β and nerve growth factor in the striatum
- 26 June 1998
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 250 (1), 25-28
- https://doi.org/10.1016/s0304-3940(98)00427-3
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 29 references indexed in Scilit:
- Upregulation of the Anti-apoptotic Protein Bcl-2 May Be an Early Event in Neurodegeneration: Studies on Parkinson's and Incidental Lewy Body DiseaseBiochemical and Biophysical Research Communications, 1997
- Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brainJournal of Neural Transmission, 1996
- Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's diseaseNeuroscience Letters, 1996
- The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseasesBrain Research Reviews, 1995
- Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease.JCI Insight, 1995
- Neurotrophic factor therapy for nervous system degenerative diseasesJournal of Neurobiology, 1994
- Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patientsNeuroscience Letters, 1994
- Promising Protein for Parkinson'sScience, 1993
- Fresh factors to considerNature, 1991
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976